Zurich's Ahead Health Raises $10 Million for AI-Powered Healthcare
Ahead Health, a Zurich-based preventive healthcare company, has successfully raised $10 million in a funding round led by venture capital firms 3VC and RTP Global. The company specializes in early detection of diseases such as cancer and liver disorders, offering personalized action plans through whole-body MRI scans and blood tests.
Expansion Plans
Founded by Nick Lenten and Vinsensius Vega, who serve as CEO and CTO respectively, Ahead Health is set to expand its AI-driven healthcare services beyond Switzerland. Already operational in Zurich, the company is now preparing to enter the German and Dutch markets. "We built Ahead in Switzerland to prove that prevention can be rigorous, fast, and useful," said Lenten. "From today, people in Munich can book a preventive check-up, with the Netherlands opening the waitlist."
Strategic Use of Funds
The $10 million will be utilized to facilitate Ahead Health's geographic expansion and enhance its technological capabilities. The company aims to make preventive healthcare more accessible across Europe, focusing initially on Germany and the Netherlands as new markets.
Investor Confidence
Peter Lasinger, Partner at 3VC, expressed confidence in the company's mission-driven approach and technical expertise, stating, "We back only a handful of teams each year, looking for founders tackling the world’s most essential causes. Ahead Health stands out because they combine a deeply mission-driven culture, with absolute rigour and deep technical excellence."
Future Outlook
With this new funding, Ahead Health is poised to broaden its impact in the preventive healthcare sector. As it gears up to launch in Germany and the Netherlands, the startup is assembling a team of experts to support its expansion and further its goal of transforming healthcare across Europe.